Although CDKN2A was first identified in 1994, followed by cyclin-dependent kinase 4 (CDK4) in 1996, most familial melanoma genes were only discovered after 2010 when next-generation sequencing technologies were introduced [46,47,48,49]. This evidence concerns the gene CDK4 and melanoma.